|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07D 471/14 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07D 495/04 | (2006.01) | ||
| C07D 519/00 | (2006.01) | ||
| A61K 31/4985 | (2006.01) | ||
| C07D 487/14 | (2006.01) | ||
| A61K 31/381 | (2006.01) | ||
| A61K 31/4353 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3521288 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19152979.1 |
| Date of filing the European patent application | 2012-11-02 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161555393 P | 2011-11-03 | US |
| (72) |
CRAWFORD, James John , US
ORTWINE, Daniel Fred , US
WEI, BinQing , US
YOUNG, Wendy B. , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY |
| HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY |